UK markets open in 46 minutes

Fresh Tracks Therapeutics, Inc. (FRTX)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.9390+0.0389 (+4.32%)
At close: 03:35PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 5.61M
Enterprise value -3.32M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.63
Price/book (mrq)0.56
Enterprise value/revenue -0.41
Enterprise value/EBITDA 0.59

Trading information

Stock price history

Beta (5Y monthly) 0.49
52-week change 370.91%
S&P500 52-week change 325.59%
52-week high 31.1000
52-week low 30.4900
50-day moving average 30.9112
200-day moving average 30.8648

Share statistics

Avg vol (3-month) 316.5k
Avg vol (10-day) 324.84k
Shares outstanding 55.97M
Implied shares outstanding 65.97M
Float 84.65M
% held by insiders 11.60%
% held by institutions 121.00%
Shares short (30 Nov 2023) 450.18k
Short ratio (30 Nov 2023) 40.69
Short % of float (30 Nov 2023) 40.85%
Short % of shares outstanding (30 Nov 2023) 40.84%
Shares short (prior month 31 Oct 2023) 426.46k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 303 Sept 2019
Ex-dividend date 4N/A
Last split factor 21:45
Last split date 305 Jul 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -71.12%
Operating margin (ttm)-79.44%

Management effectiveness

Return on assets (ttm)-36.37%
Return on equity (ttm)-66.50%

Income statement

Revenue (ttm)8.01M
Revenue per share (ttm)1.48
Quarterly revenue growth (yoy)-100.00%
Gross profit (ttm)N/A
EBITDA -6.32M
Net income avi to common (ttm)-5.69M
Diluted EPS (ttm)-1.0600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)10.87M
Total cash per share (mrq)1.82
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)6.98
Book value per share (mrq)1.66

Cash flow statement

Operating cash flow (ttm)-4.34M
Levered free cash flow (ttm)-2.67M